Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.31 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16512009 | 0.95 | DRD1 (0.56) | DRD1 | |
| SCHEMBL29501652 | 0.93 | DRD1 (0.55) | DRD1 | |
| SCHEMBL21111854 | 0.93 | DRD1 (0.55) | DRD1 | |
| SCHEMBL29501658 | 0.93 | DRD1 (0.55) | DRD1 | |
| SCHEMBL1781629 | 0.92 | DRD1 (0.53) | DRD1 | |
| SCHEMBL21111888 | 0.92 | DRD1 (0.57) | DRD1 | |
| SCHEMBL16512415 | 0.91 | DRD1 (0.52) | DRD1 | |
| SCHEMBL21111795 | 0.90 | DRD1 (0.51) | DRD1 | |
| SCHEMBL21111784 | 0.90 | DRD1 (0.51) | DRD1 | |
| SCHEMBL29501684 | 0.90 | DRD1 (0.51) | DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124805-B2 | Allyl acetate hydroformylation process | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2012-02-28 | — | — | US | claimed |
| US-20110124904-A1 | Allyl acetate hydroformylation process | LYONDELL CHEMICAL TECHNOLOGY, L.P. | 2011-05-26 | — | — | US | claimed |
| EP-3197905-B1 | METHOD FOR PRODUCING ETHYLENEDIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS, AND THE USE THEREOF AS FLAME RETARDANTS | CLARIANT INT LTD (CH) | 2021-06-30 | — | — | EP | disclosed |
| US-20200407373-A1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA, INC. | 2020-12-31 | — | — | US | disclosed |
| EP-1501784-B1 | INTEGRATED CHEMICAL PROCESSES FOR INDUSTRIAL UTILIZATION OF SEED OILS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-03-13 | — | — | EP | disclosed |
| US-20170267836-A1 | Process For Preparing Ethylenedialkylphosphinic Acids, Esters And Salts And Use Thereof | CLARIANT PLASTICS & COATINGS LTD (CH) | 2017-09-21 | — | — | US | disclosed |
| EP-3197905-A1 | METHOD FOR PRODUCING ETHYLENEDIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS, AND THE USE THEREOF AS FLAME RETARDANTS | Clariant Plastics & Coatings Ltd (CH) | 2017-08-02 | — | — | EP | disclosed |
| EP-2379575-B1 | HYDROPHOSPHORYLATION OF PHOSPHONIC ACID DERIVATIVES TO YIELD FLAME RETARDANTS | CLARIANT INT LTD (CH) | 2017-04-12 | — | — | EP | disclosed |
| WO-2016045976-A1 | METHOD FOR PRODUCING ETHYLENEDIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS, AND THE USE THEREOF AS FLAME RETARDANTS | CLARIANT INTERNATIONAL LTD (CH) | 2016-03-31 | — | — | WO | disclosed |
| US-9279085-B2 | Method for the production of monofunctionalized dialkylphosphinic acids, esters and salts, and use thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2016-03-08 | — | — | US | disclosed |
| EP-2379572-B1 | METHOD FOR THE PRODUCTION OF MONOFUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, ESTERS, AND SALTS, AND USE THEREOF | CLARIANT INT LTD (CH) | 2015-12-23 | — | — | EP | disclosed |
| US-20080108823-A1 | Method For Producing Thioether Compound | MSD K.K. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-7368597-B2 | Carbonylation process using metal-polydentate ligand catalysts | BP CHEMICALS LIMITED (GB) | 2008-05-06 | — | — | US | disclosed |
| US-7276626-B2 | Carbonylation process using metal-tridentate ligand catalysts | BP CHEMICALS LIMITED (GB) | 2007-10-02 | — | — | US | disclosed |
| US-20070083066-A1 | Method for the production of 1,7-octadiene and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20070083066-A1 | Method for the production of 1,7-octadiene and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-7173138-B2 | Ligands for pnicogen chelate complexes with a metal of subgroup VIII and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-06 | — | — | US | disclosed |
| US-7173138-B2 | Ligands for pnicogen chelate complexes with a metal of subgroup VIII and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-06 | — | — | US | disclosed |
| US-20070010687-A1 | Carbonylation process using metal-polydentate ligand catalysts | BP CHEMICALS LIMITED (GB) | 2007-01-11 | — | — | US | disclosed |
| US-20050154221-A1 | Integrate chemical processes for industrial utilization of seed oils | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2005-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170267836-A1 | Process For Preparing Ethylenedialkylphosphinic Acids, Esters And Salts And Use Thereof | ENPP1, ENPP3, FADS2 | DRD1 3746/4885CYP3A4 1208/4885TDP1 1308/4885 |
| US-20070083066-A1 | Method for the production of 1,7-octadiene and use thereof | CYP51A1, MSMO1, HSD17B7 | DRD1 92/4885CYP3A4 128/4885TDP1 2713/4885 |
| US-20200407373-A1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | BTD, BLVRB, BLK | DRD1 3180/4885CYP3A4 471/4885TDP1 2088/4885 |
| US-20050154221-A1 | Integrate chemical processes for industrial utilization of seed oils | ALOX12, SQLE, ALOX15 | DRD1 1246/4885CYP3A4 440/4885TDP1 3504/4885 |
| US-20080108823-A1 | Method For Producing Thioether Compound | TST, MPST, PPIP5K2 | DRD1 557/4885CYP3A4 1947/4885TDP1 3155/4885 |
| US-20070010687-A1 | Carbonylation process using metal-polydentate ligand catalysts | ADH5, ADH1C, ADH1A | DRD1 167/4885CYP3A4 523/4885TDP1 4130/4885 |
| US-20110124904-A1 | Allyl acetate hydroformylation process | GNPAT, DHPS, ALDH3A1 | DRD1 2526/4885CYP3A4 317/4885TDP1 3781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.